Frank Mccormick

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
San Francisco, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Will Solis, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Frank Mccormick

Form 4 holding Director

BridgeBio Pharma, Inc.

Security class
Common Stock
Shares / value
756,665
Estimated value
$56,189,942
Report date
22 Jun 2026
Price
$74.26
Ownership
By the Francis P. McCormick Rev Trust U/A DTD 1/27/2017

Insider Reports Filed by Frank Mccormick

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .